Mandy Lauw: International Collaboration Provides New Evidence for Splanchnic Vein Thrombosis Care
Mandy Lauw, Internist-Hematologist at Erasmus MC, reposted from JTH on LinkedIn, about a recent article she and her colleagues co-authored, published in JTH, adding:
”Proud of this important publication on splanchnic vein thrombosis (SVT) by our PhD-student Amica Ko.
- Similar recurrence, bleeding and survival outcomes of SVT with MPN and without MPN
- Patients with MPN and SVT can likely be treated similarly to patients with non-cirrhosis, non-malignancy associated SVT
Work in close partnership with Italian colleagues Laura Milana, Nicoletta Riva and Walter Ageno.
And thanks to collaborators of the 3 included studies from across the world, among which Marc Carrier, Peter Verhamme, Laurent Bertoletti, Aurelien Delluc Pieter, Willem Kamphuisen, Alejandro Lazo Langner, Elvira Grandone, Alberto Tosetto, Frank Leebeek.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Does a myeloproliferative neoplasm change the outlook after splanchnic vein thrombosis?
In this large cohort, rates of recurrent thrombosis, bleeding, and survival at six months were similar whether or not patients had an MPN.
The authors suggest MPN-related splanchnic vein thrombosis can be managed much like noncirrhotic, nonmalignant disease, while longer prospective follow-up is still needed.”
Title: Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Authors: Amica K. Ko, Laura Milana, Nicoletta Riva, Lorenza Bertu, Laurent Bertoletti, Jan Beyer-Westendorf, Marc Carrier, Aurelien Delluc, Elvira Grandone, Pieter Kamphuisen, Alejandro Lazo-Langner, Margherita Maffioli, Daniela Poli, Sam Schulman, Marco Senzolo, Sophie Testa, Alberto Tosetto, Peter Verhamme, Frank W.G. Leebeek, Sarwa Darwish Murad, Walter Ageno, Mandy N. Lauw
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?